Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19047220 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine
Conditions: Hepatitis B;   Poliomyelitis;   Diphtheria;   Tetanus;   Acellular Pertussis
Interventions: Biological: Pediarix;   Biological: Licensed DTPa containing vaccine;   Biological: Prevnar®: (Wyeth)

Indicates status has not been verified in more than two years